Multiple Sclerosis

Latest News

Internuclear Ophthalmoparesis in Multiple Sclerosis: What’s the Prevalence?

Publish Date May 23, 2022

Researchers sought to characterize the prevalence and clinical features of individuals with both MS and INO in a population-based cohort of patients with MS.

Effect of Alemtuzumab on Blood Pressure in Patients With Multiple Sclerosis

Publish Date May 19, 2022

Researchers sought to assess the change in blood pressure in patients with MS treated with ATZ and prior HDMP treatment compared with patients receiving HDMP only for acute relapse.

Can Childhood Trauma Increase the Risk for Multiple Sclerosis in Women?

Publish Date May 11, 2022

In a prospective cohort study, researchers assessed whether adverse childhood experiences may increase the risk for multiple sclerosis in women.

Having MS May Impact Cancer Screening, Diagnosis

Publish Date May 11, 2022

For individuals with MS and cancer, breast cancers are less likely to be detected through screening and colorectal cancer is more likely to be detected at an early stage.

Prevalence of MS Similarly High in Black, White Individuals

Publish Date May 11, 2022

The prevalence of multiple sclerosis (MS) is similarly high in Black and White individuals and is lower in Hispanics and Asians.

Total Economic Burden of MS Was $85.4 Billion in US in 2019

Publish Date April 27, 2022

The total economic burden of multiple sclerosis (MS) in the United States in 2019 was $85.4 billion, including $63.3 billion in direct medical costs.

Sexual, Emotional Abuse in Childhood May Up Multiple Sclerosis Risk

Publish Date April 11, 2022

Childhood sexual and emotional abuse are associated with an increased risk for developing multiple sclerosis (MS) in women.

Ublituximab Shows Benefit Among Patients With Relapsing Multiple Sclerosis

Publish Date April 6, 2022

Using data from the Ultimate I and II phase 3 trials, researchers conducted a post-hoc analysis to study the effects of ublituximab on disease activity in relapsing multiple sclerosis.

Functional MRI Reveals Cognitive Issues in Pediatric Patients With Multiple Sclerosis

Publish Date April 6, 2022

Presenting at the 2022 AAN Annual Meeting, researchers assessed the neuropsychological profile of pediatric MS and its association with resting-state functional connectivity abnormalities in cognitive and motor networks.

Atypical Optical Neuritis Induced By Golimumab Treatment for Psoriasis Arthritis

Publish Date April 6, 2022

Presenting at the 2022 AAN Annual Meeting, researchers evaluated a case of 48-year-old woman who developed atypical optic neuritis induced by golimuab treatment.